Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options

Autosomal dominant polycystic kidney disease (ADPKD) is the reported etiology in 10% of end-stage kidney disease (ESKD) patients and has an estimated prevalence of 12.5 million cases worldwide across all ethnicities. There have been major advancements over the last two decades in understanding the p...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Yeshwanter Radhakrishnan (Egilea), Parikshit Duriseti (Egilea), Fouad T. Chebib (Egilea)
Formatua: Liburua
Argitaratua: The Korean Society of Nephrology, 2022-07-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri